143 related articles for article (PubMed ID: 12845646)
1. Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cells.
Buttiglieri S; Galetto A; Forno S; De Andrea M; Matera L
Int J Cancer; 2003 Sep; 106(4):516-520. PubMed ID: 12845646
[TBL] [Abstract][Full Text] [Related]
2. Drug- and cell-mediated antitumor cytotoxicities modulate cross-presentation of tumor antigens by myeloid dendritic cells.
Galetto A; Buttiglieri S; Forno S; Moro F; Mussa A; Matera L
Anticancer Drugs; 2003 Nov; 14(10):833-43. PubMed ID: 14597879
[TBL] [Abstract][Full Text] [Related]
3. Contribution of dendritic cells' FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies.
Signorino E; Brusa D; Granata R; Malavasi F; Ferrone S; Matera L
Cancer Biol Ther; 2007 Dec; 6(12):1932-7. PubMed ID: 18087220
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo host response to gastrointestinal cancer cells presented by autologous dendritic cells.
Galetto A; Contarini M; Sapino A; Cassoni P; Consalvo E; Forno S; Pezzi C; Barnaba V; Mussa A; Matera L
J Surg Res; 2001 Sep; 100(1):32-8. PubMed ID: 11516202
[TBL] [Abstract][Full Text] [Related]
5. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.
Pietra G; Mortarini R; Parmiani G; Anichini A
Cancer Res; 2001 Nov; 61(22):8218-26. PubMed ID: 11719453
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates.
Ferlazzo G; Semino C; Spaggiari GM; Meta M; Mingari MC; Melioli G
Int Immunol; 2000 Dec; 12(12):1741-7. PubMed ID: 11099314
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells.
Hoffmann TK; Meidenbauer N; Müller-Berghaus J; Storkus WJ; Whiteside TL
J Immunother; 2001; 24(2):162-71. PubMed ID: 11265774
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of HSP70 by colon cancer cells is not always associated with access to the dendritic cell cross-presentation pathway.
Matera L; Forno S; Galetto A; Moro F; Garetto S; Mussa A
Cell Mol Biol Lett; 2007; 12(2):268-79. PubMed ID: 17235439
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells.
Noessner E; Gastpar R; Milani V; Brandl A; Hutzler PJ; Kuppner MC; Roos M; Kremmer E; Asea A; Calderwood SK; Issels RD
J Immunol; 2002 Nov; 169(10):5424-32. PubMed ID: 12421917
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.
Lu WW; Zhang H; Li YM; Ji F
World J Gastroenterol; 2017 Jun; 23(24):4390-4398. PubMed ID: 28706421
[TBL] [Abstract][Full Text] [Related]
11. Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity.
Brusa D; Garetto S; Chiorino G; Scatolini M; Migliore E; Camussi G; Matera L
Vaccine; 2008 Nov; 26(50):6422-32. PubMed ID: 18848858
[TBL] [Abstract][Full Text] [Related]
12. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
[TBL] [Abstract][Full Text] [Related]
13. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J
J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses.
Nouri-Shirazi M; Banchereau J; Bell D; Burkeholder S; Kraus ET; Davoust J; Palucka KA
J Immunol; 2000 Oct; 165(7):3797-803. PubMed ID: 11034385
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells.
Ebstein F; Sapede C; Royer PJ; Marcq M; Ligeza-Poisson C; Barbieux I; Cellerin L; Dabouis G; Grégoire M
Am J Respir Crit Care Med; 2004 Jun; 169(12):1322-30. PubMed ID: 15070823
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells.
Brusa D; Migliore E; Garetto S; Simone M; Matera L
Prostate; 2009 Sep; 69(12):1343-52. PubMed ID: 19496055
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells.
Bohnenkamp HR; Burchell JM; Taylor-Papadimitriou J; Noll T
J Immunol Methods; 2004 Nov; 294(1-2):67-80. PubMed ID: 15604017
[TBL] [Abstract][Full Text] [Related]
18. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen.
Labarrière N; Bretaudeau L; Gervois N; Bodinier M; Bougras G; Diez E; Lang F; Gregoire M; Jotereau F
Int J Cancer; 2002 Sep; 101(3):280-6. PubMed ID: 12209980
[TBL] [Abstract][Full Text] [Related]
20. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
